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Association of Limb-Girdle muscular dystrophy with 
multiple sclerosis: A case report 
Abstract 
Background: The association of limb-girdle muscular dystrophy (LGMD) with other 
neurological disorders is uncommon. 
Case presentation: We report a 25-year-old female with LGMD who suffered from slowly 
progressive proximal muscular weakness and atrophy since she was 12 years of age. The 
patient recently presented with acute loss of left side visual acuity. After evaluation, 
findings were suggestive of multiple sclerosis. 
Conclusions: This is the first report of LGMD in association with MS. The simultaneous 
occurrence of MS with myopathies may be incidental but there may be a genetic 
susceptibility for both diseases. This comorbidity may influence the treatment of MS. 
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Limb-girdle muscular dystrophy (LGMD) denominates a group of diseases that 
involve proximal muscles in childhood or adulthood. It is sometimes associated with 
elevated creatine phosphokinase serum levels and indicated by dystrophic changes 
(regeneration/degeneration) on muscle biopsy. The age of onset, severity, and systemic 
organ involvement varies among different subtypes. In addition,  the signs and symptoms 
are different among the members of one family (1, 2). We report a known case of LGMD 
that presented with left optic neuritis during the follow-up. After investigation, a diagnosis 
of multiple sclerosis (MS) was made based on the magnetic resonance imaging (MRI) 
findings. 
 
Case Presentation 
The patient was a 25-year-old female born to non-consanguineous parents. She was the 
second child of a family with one brother and two sisters. Her initial symptom began when 
she was 12 years old and presented as difficulty in climbing stairs. Her weakness was 
slowly progressive with the wasting of the proximal leg muscles so that she lost her ability 
to run. After a few years, she also felt weak in her shoulders and arms but to a lesser 
degree than her legs. She did not have any sensory or sphincter complaints. Her 
swallowing was normal. A family history of muscle weakness was positive in her 
grandmother, but it was not debilitating enough to look for a cause. One of her aunts had 
MS. Her history was negative for alcohol and smoking. She only took multivitamin pills 
temporarily. On examination, her body-mass index (BMI) was 23 and she was afebrile 
with no abnormal findings on physical examination of the skin, mucous, head, and neck. 
Cardiopulmonary and abdominopelvic examinations showed no abnormalities. She was 
fully obedient and her mental functions were intact with normal speech. An examination of 
her cranial nerves showed no facial or bulbar muscle involvement. Muscle weakness and 
atrophy was symmetrical, prominent in the pelvic and shoulder girdle sparing 
oculofaciobulbar muscles.  
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The muscles had a normal tonus without any evidence of 
contracture or calf hypertrophy. She had good strength in her 
axial muscles (5/5). Weakness was more obvious in the 
lower limbs than in the upper limbs (3/5 and 4/5, 
respectively). The power of her distal muscles, wrists, and 
feet was preserved. Her tendon reflexes diminished 
proportional to their weakness. Plantar reflexes were down 
bilaterally. Sensory examination was normal. Laboratory 
tests performed at that time showed an increased level of 
transaminases (ALT: 72 U/L, AST: 55U/L) and CPK 10000 
U/L. Cardiologic consultation revealed no significant cardiac 
abnormalities.  
The first electromyography (EMG) (2005) showed a 
myopathic pattern in the lower limbs from which a muscle 
biopsy was requested but the patient postponed it. Until the 
patient was 20 years old, her symptoms were progressive; 
then, she experienced a stabilization of the disease. A biopsy 
taken in 2011 revealed dystrophic changes (degeneration/ 
regeneration) with markedly increased endomysial 
connective tissue; no inflammatory cell infiltration, ragged 
red fiber, cytoplasmic body and lipid or glycogen 
accumulation in muscle fibers were seen (fig.1). An 
immunohistochemistry (IHC) study of sarcolemmal proteins 
showed sarcolemma labeling of all fibers with DYS1, DYS2, 
DYS3, alpha and gamma sarcoglycan, dysferlin, merosin, 
and beta-spectrin (fig.2).  
The second EMG in 2011 showed a myopathic process 
pronounced in the proximal muscles. With a diagnosis of 
LGMD, rehabilitation, physical therapy, and stretching 
exercises were advised to improve her mobility and prevent 
disused atrophy or contracture deformities. In April 2015, 
she complained of acute left visual loss for four days with 
painful eye movements that lasted for several days. Her 
muscle strength had not changed for 5 years. On examination 
of her pupils, the left one had 2+ relative afferent pupillary 
defects (RAPD). Left visual acuity was finger counting from 
one meter with cecocentral scotoma in the visual field. 
Extraocular muscles and other cranial nerves were intact. 
Ophthalmologic consultation revealed no bulbar ophthalmic 
problems. For further evaluation, we planned a brain and 
optic pathway MRI that excluded compressive lesions of the 
optic pathway and disclosed multiple periventricular, 
centrum semiovale, corpus callosum, juxta cortical, and infra 
tentorial (brain stem and cerebellum) T2 hypersignal 
demyelinating plaques with multiple lesion enhancement (fig 
3) that fulfilled the McDonald criteria for MS (3, 4). 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: H&E staining: atrophy, some necrotic and 
regenerative fibers are noted. Endomysial connective 
tissue is severely increased. 
 
 
 
 
 
 
 
 
 
 
Fig 2. Immunohistochemistry (IHC) shows staining with 
anti-dystrophin, dysferlin, merosin, and sarcoglycan. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3. a) Sagittal T2 MRI, multiple hyperintense lesions 
involving periventricular white matter thalamus and 
cerebellum; b) Sagittal T1-weighted MRI showed enhancement 
of one periventricular lesion; c) and d) Axial T2 and FLAIR 
MRI, respectively; demonstrating multiple periventricular, 
centrum semioval, and juxtacortical lesions. 
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From this, we prescribed intravenous methyl 
prednisolone (5 gr divided in 5 days) for the treatment of her 
optic neuritis. She responded significantly and her visual 
acuity ameliorated so that she could read from 30 cm. 
Vasculitis tests and anti-aquaporin 4 antibodies were 
negative.  The final diagnosis was relapsing-remitting MS 
(RRMS). For long term treatment, we decided to put her on a 
glatiramer acetate daily injection. 
 
 
Discussion 
This is the first report of LGMD in association with MS. 
Mutations in more than 50 loci have been known for LGMD. 
LGMD is distinct from x-linked muscular dystrophy by the 
autosomal pattern of inheritance, and from 
facioscapulohumeral and Emery muscular dystrophy by 
sparing the facial muscles. A proximal muscle involvement 
will become evident either in late childhood or early 
adulthood and is relatively benign in comparison with 
Duchenne dystrophy. Cardiac involvement occurs in some 
subtypes of the disease and mental functions are usually 
normal (5-8). 
No definitive treatment exists for LGMD; however, 
management should be based for weight control, 
rehabilitation, physiotherapy, orthopedic surgery for skeletal 
deformities, and if respiratory failure occurs, then the use of 
respiratory aids and a mechanical ventilator is required (9-
11). Although some reports suggest an association between 
myopathy and other neurological disorders, evidence is 
lacking to conclude this relationship.  
MS is another disabling neurologic disease, the most 
common autoimmune disorder affecting the central nervous 
system and is believed to occur as a result of genetics 
(including HLA DR15 and DQ56) and environmental factors 
(12). In recent years, the role of mitochondrial dysfunction in 
axonal loss degeneration in the progressive stage of MS has 
been investigated (13). 
Some cases of MS and myopathy have been reported, for 
example, one case with centronuclear myopathy and RRMS 
(14). A 31-year-old woman with myotonic dystrophy type 2 
presented with left hemihyperesthesia and mild spinal cord 
and brain stem symptoms whose paraclinical findings 
provided a diagnosis of RRMS (15). Two cases with 
mitochondrial myopathy and MS have been reported (16). 
The association of facioscapulohumeral muscular dystrophy 
and MS in a man with a history of bilateral pectoralis, 
proximal weakness, and atrophy of upper extremities since 
he was 16 years old showed left optic neuritis as the first 
presentation of MS at age 23 (17). A 27-year-old woman 
with progressive proximal lower limb weakness and 
increased liver function tests since her 20s with evidence of 
MS based on a brain MRI, cerebrospinal fluid, and visual 
evoked potential and in combination with an observation of 
periodic acid-Schiff (PAS) positive vacuoles on her muscle 
biopsy that was conclusive for adult onset Pompe disease 
with PPMS (18). The simultaneous occurrence of MS with 
myopathies may be incidental but there may be a genetic 
susceptibility for both diseases. 
In conclusion the comorbidity between MS and others 
medical disorders is important for the treatment of this 
autoimmune disease. As the authors know this is the first 
report of MS in association with LGMD. 
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